Xiaopeng Mao
Impact in
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 2
- Phytochemical compounds biological activities 1
-
- Renal cell carcinoma treatment 4
- Ferroptosis and cancer prognosis 1
- Co-authors
- Chengqiang Mo (7 shared papers)Shengjie Guo (6 shared papers)Bin Huang (6 shared papers)Shaopeng Qiu (6 shared papers)Junxing Chen (5 shared papers)Jintao Zhuang (3 shared papers)Zunfu Ke (3 shared papers)Liantang Wang (3 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Developmental Cell (1 paper)Cancer Cell International (1 paper)PLoS ONE (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- ChinaIrelandUnited States
In The Last Decade
Xiaopeng Mao
19 papers receiving 459 citations
Peers
Comparison fields: 5 of 50
- Pathology and Forensic Medicine 143
- Cancer Research 102
- Urology 26
- Oncology 97
- Molecular Biology 222
Countries citing papers authored by Xiaopeng Mao
This map shows the geographic impact of Xiaopeng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Mao more than expected).
Fields of papers citing papers by Xiaopeng Mao
This network shows the impact of papers produced by Xiaopeng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Mao. The network helps show where Xiaopeng Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopeng Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 81 | |
| 2 | 2014 | 76 | |
| 3 | 2010 | 68 | |
| 4 | 2013 | 46 | |
| 5 | 2011 | 42 | |
| 6 | 2022 | 32 | |
| 7 | 2011 | 23 | |
| 8 | 2014 | 21 | |
| 9 | 2018 | 17 | |
| 10 | 2022 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2012 | 11 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 2 | |
| 16 | 2014 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2020 | 1 | |
| 20 | 2022 | 0 |
About Xiaopeng Mao
Xiaopeng Mao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Oncology, having authored 20 papers that have together received 463 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Mechanisms and Therapy (3 papers), Circular RNAs in diseases (2 papers), Biomarkers in Disease Mechanisms (1 paper), Ferroptosis and cancer prognosis (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Phytochemical compounds biological activities (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (143 citations), Cancer Research (102 citations), Urology (26 citations), Oncology (97 citations) and Molecular Biology (222 citations). Xiaopeng Mao has collaborated with scholars based in China, Ireland and United States. Frequent co-authors include Chengqiang Mo, Shengjie Guo, Bin Huang, Shaopeng Qiu, Junxing Chen, Jintao Zhuang, Zunfu Ke, Liantang Wang, Lingwu Chen and Jin Chu. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Developmental Cell, Cancer Cell International, PLoS ONE and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.